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DObjective: To assess the ability of urinary acute kidney injury biomarkers and renal near-infrared spectroscopy
(NIRS) to predict outcomes in infants after surgery for congenital heart disease.
Methods: Urinary levels of neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), kidney
injury molecule-1 (KIM-1), and cystatin C were measured preoperatively and postoperatively in 49 infants
younger than 6 months of age. Renal NIRS was monitored for the first 24 hours after surgery. A composite
poor outcome was defined as death, the need for renal replacement therapy, prolonged time to first extubation,
or prolonged intensive care unit length of stay.
Results: Forty-two (86%) patients had acute kidney injury as indicated by at least Acute Kidney Injury Net-
work/Kidney Disease: Improving Global Outcomes (AKIN/KDIGO) stage 1 criteria, and 17 (35%) patients
had poor outcomes, including 3 deaths. With the exception of KIM-1, all biomarkers demonstrated significant
increases within 24 hours postoperatively among patients with poor outcomes. Low levels of NGAL and IL-18
demonstrated high negative predictive values (91%) within 2 hours postoperatively. Poor outcome infants had
greater cumulative time with NIRS saturations less than 50% (60 vs 1.5 minutes; P ¼ .02) in the first 24 hours.
Conclusions:Within the first 24 hours after cardiopulmonary bypass, infants at increased risk for poor outcomes
demonstrated elevated urinary NGAL, IL-18, and cystatin C and increased time with low NIRS saturations.
These findings suggest that urinary biomarkers and renal NIRS may differentiate patients with good versus
poor outcomes in the early postoperative period, which could assist clinicians when counseling families and
inform the development of future clinical trials. (J Thorac Cardiovasc Surg 2013;146:861-7)C
HSupplemental material is available online.
Acute kidney injury (AKI) is a common and potentially
serious complication after surgery for congenital heart dis-
ease. Depending on the study population and criteria used to
defineAKI, contemporary studies report an incidence ranging
from 5.5% to 50%, with associated mortality ranging from
20% to 61%.1-3 Well-established risk factors include young
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Although they represent a high-risk population, infants often
only comprise a small proportion of the study patients, and,
because AKI is ill-defined in neonates, they are often entirely
excluded.4
To standardize the definition of AKI, expert consensus
groups have created the RIFLE (Risk, Injury, Failure,
Loss, End-stage kidney disease) and AKIN (Acute Kidney
Injury Network) scoring systems, which are based on
changes in serum creatinine (SCr) and urine output.
5,6
Modification and application of the RIFLE criteria to
pediatrics (pRIFLE) has been shown to predict morbidity
and mortality in critically ill children.7 In addition, a modi-
fied version of the AKIN criteria has also been shown to
portend a poor clinical outcome in infants after surgery
for congenital heart disease.8 Although these systems repre-
sent important advancements in the standardization of AKI
diagnosis, they have limited clinical utility in the perioper-
ative period owing to delayed and unpredictable changes in
SCr and urine output after CPB. Creatinine-based measures
of AKI are particularly limited in neonates owing to the in-
fluence of maternal SCr, low glomerular filtration rates, and
effect of serum bilirubin on the assay itself.4
Efforts to improve the sensitivity, accuracy, and timeli-
ness of AKI diagnosis have resulted in the clinical testingrdiovascular Surgery c Volume 146, Number 4 861
Abbreviations and Acronyms
AKI ¼ acute kidney injury
AKIN ¼ Acute Kidney Injury Network
CPB ¼ cardiopulmonary bypass
ECMO ¼ extracorporeal membrane
oxygenation
ICU ¼ intensive care unit
IL-18 ¼ interleukin 18
KDIGO ¼ Kidney Disease: Improving Global
Outcomes
KIM-1 ¼ kidney injury molecule-1
NGAL ¼ neutrophil gelatinase-associated
lipocalin
NIRS ¼ near-infrared spectroscopy
pRIFLE ¼ RIFLE criteria modified to pediatrics
RACHS-1 ¼ Risk Adjustment for Congenital
Heart Surgery 1
RIFLE ¼ Risk, Injury, Failure, Loss, End-stage
kidney disease
RRT ¼ renal replacement therapy
rSO2 ¼ regional oxyhemoglobin saturation
SCr ¼ serum creatinine
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Dof renal injury biomarkers. The molecules neutrophil
gelatinase-associated lipocalin (NGAL), interleukin 18
(IL-18), kidney injury molecule-1 (KIM-1), and cystatin
C are increased in the blood and/or urine of critically ill
adults and children with AKI in a variety of clinical set-
tings.9 After surgery for congenital heart disease, these bio-
markers are elevated within 12 hours of CPB in patients in
whom AKI develops by SCr.
10-13
Near-infrared spectroscopy (NIRS) uses an infrared light
source to measure regional oxyhemoglobin saturation
(rSO2) continuously and noninvasively 1.5 to 2 cm into
the tissue bed of interest.14 It has the advantage of being
noninvasive, real time, and specific to the organ of interest.
Saturation values obtained from cerebral and flank NIRS
probes are correlated with invasive mixed venous oxygen
saturations after surgery for congenital heart disease.15 In
addition, low rSO2 values have been correlated with injury
to the brain, gut, and kidney after CPB in children.16-18
To date, urinary biomarkers and renal NIRS have not
been simultaneously evaluated after surgery for congenital
heart disease and correlated with outcome. We hypothe-
sized that infants with perioperative kidney injury identified
by elevated urinary biomarkers or low renal NIRS values
would have comparatively poorer clinical outcomes.METHODS
This prospective study was approved by the Institutional Review Board
at the University of Michigan. Infants under 6 months of age undergoing862 The Journal of Thoracic and Cardiovascular Surgcardiac surgery with CPB between July 2009 and July 2010 were eligible
for enrollment. Fifty families were approached, and 1 family declined par-
ticipation in the study. Premature infants less than 35 weeks’ gestation were
excluded. After parental or guardian informed consent was obtained,
patient demographic and surgical information was collected. Surgical com-
plexity was ranked according to the Risk Adjustment for Congenital Heart
Surgery 1 (RACHS-1) scoring system.19 Postoperative hemodynamic sta-
tus was estimated by calculation of a daily maximum vasoactive–inotropic
score (VIS) for the first 3 days after surgery as per the equation below20:
VIS ¼ dopamine dose mg $ kg1 $ min1
þ dobutamine dose mg $ kg1 $ min1
þ 100 $ epinephrine dose mg $ kg1 $ min1
þ 10 $ milrinone dose mg $ kg1 $ min1
þ 10; 000 $ vasopressin dose units $ kg1 $ min1
þ 100 $ norepinephrine dose mg $ kg1 $ min1
All patients received routine standard of care during the study period,
which included the use of dextrose-containing crystalloid solutions
(75-100 mL $ kg1 $ d1) during the first 24 to 48 hours postoperatively,
followed by the initiation of total parenteral nutrition. Patients were started
on bolus furosemide (1 mg/kg per dose every 6 hours) within the first 24
hours postoperatively. One of the study patients had a peritoneal drain
placed for mild abdominal compartment syndrome. Primary providers
were aware that the patients were enrolled in a study looking at AKI and
outcomes.
Biomarkers
Preoperative urine samples were collected from a bag specimen or in-
dwelling catheter placed in the operating room before initiation of CPB.
Postoperative urine samples were obtained from the Foley catheter on ad-
mission to the intensive care unit (ICU) and at 2, 6, 12, and 24 hours. The
samples were centrifuged (2000 rpm, 5 minutes), divided into aliquots, and
stored (80C) until analysis. Urinary concentrations of NGAL, IL-18,
KIM-1, and cystatin C were measured using commercially available
enzyme-linked immunosorbent assay kits from R&D Systems (Minneapo-
lis, Minn).
Near-Infrared Spectroscopy
After arrival in the ICU, a Somanetics (Troy, Mich) INVOS Pediatric
NIRS sensor was placed over the right flank and continuous rSO2 was
recorded in 30-second intervals for the first 24 hours after surgery. The pri-
mary caregivers were blinded to the data during the collection period and
no clinical interventions were made on the basis of the NIRS values. Faulty
NIRS probes were discovered in 2 patients after completion of the observa-
tion period. Because of the impact of extracorporeal membrane oxygena-
tion (ECMO) on oxygen saturation, in 6 patients NIRS data were
censored from analysis.
Acute Kidney Injury
SCr was measured preoperatively and postoperatively, then once daily as
part of routine daily laboratory studies. AKI was defined using criteria pro-
posed by the Acute Kidney Injury Network and Kidney Disease Improving
Global Outcomes group, and recently validated in a study of infants with
congenital heart disease.6,8,21 Infants had AKI if they met AKIN stage 1
criteria, defined as an increase in SCr by either 0.3 mg/dL or more or
a 50% rise from preoperative baseline within the first 3 days
postoperatively.
Outcome Measures
Owing to the relatively small size of our patient population and our low
mortality and renal replacement therapy (RRT) rates, a composite poorery c October 2013
TABLE 1. Demographics and clinical characteristics
Poor outcome
P value
Yes
(n ¼ 17)
No
(n ¼ 32)
Sex, N (%)
Female 5 (29) 9 (28) 1.00
Male 12 (71) 23 (72)
Age at surgery, d, median (IQR) 7 (5-10) 98 (33-150) .001
Preoperative weight, kg 3.7  0.7 4.9  1.4 .0002
RACHS-1 classification, N (%)
2 to 4 8 (47) 29 (91) .001
5 or 6 9 (53) 3 (9)
CPB time, min 149  61 84  35 .001
Aortic crossclamp time, min 52  40 45  25 .55
Hypothermic circulatory arrest, N (%) 10 (59) 5 (16) .003
Postoperative ECMO, N (%) 6 (35) 0 (0) .001
Maximum vasoactive inotrope score 23  9 12  7 <.0001
Peak serum creatinine, mg/dL 0.9  0.3 0.6  0.3 .005
Estimated creatinine clearance 30  10 49  17 <.0001
Acute kidney injury, N (%)
No 1 (6) 6 (19) .40
Yes 16 (94) 26 (81)
Hazle et al Congenital Heart Diseaseoutcomewas used. A poor outcomewas defined as any of the following: (1)
death within 30 days of surgery; (2) need for RRT; (3) prolonged time to
first extubation (upper quartile  6.5 days); or (4) prolonged ICU length
of stay (upper quartile  9.9 days). Normative values for ventilator time
and ICU length of stay were obtained from a contemporary internal data-
base of infants less than 6 months of age (n ¼ 395) who have undergone
cardiac surgery.
Statistical Analysis
Demographic and clinical characteristics were compared using
Student’s t test for continuous variables and Fisher’s exact test for cate-
gorical variables. The Wilcoxon rank sum test was used to evaluate the
association between each continuous biomarker or continuous NIRS sat-
uration value and the risk of a poor outcome at each postoperative hour.
To determine an optimal cutoff value for each biomarker for the diagno-
sis of a poor outcome over time, we generated a receiver operating char-
acteristic curve using a nonparametric approach under repeated
measures design.22 Unconditional (exact) odds ratios with their 95%
confidence intervals were estimated at each time point using (exact)
logistic regression to evaluate a risk of poor outcome for each biomarker
above the optimal cutoff obtained from the receiver operating character-
istic curve. Owing to the small sample size that limited the ability to per-
form multivariable analyses, unadjusted odd ratios are presented. All
analyses were performed using SAS version 9.2 (SAS Institute, Inc,
Cary, NC).
AKIN/KDIGO stage 1 11 (65) 17 (53) .81
AKIN/KDIGO stage 2 3 (18) 8 (25)
AKIN/KDIGO stage 3 2 (12) 1 (3)
Data are presented as mean  standard deviation unless otherwise indicated.
IQR, Interquartile range (25th-75th percentile); RACHS, risk adjustment for surgery
for congenital heart disease; CPB, cardiopulmonary bypass; ECMO, extracorporeal
membrane oxygenation; AKIN, Acute Kidney Injury Network; KDIGO, Kidney
Disease: Improving Global Outcomes.
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DRESULTS
A total of 49 infants were enrolled during the study pe-
riod. With the exception of 1 infant who underwent a stage
2 hemi-Fontan operation, all patients underwent surgery for
the first time to repair or palliate one of the following
primary cardiac diagnoses: ventricular septal defect
(n ¼ 12), tetralogy of Fallot (n ¼ 9), hypoplastic left heart
syndrome (n ¼ 9), atrioventricular septal defect (n ¼ 6),
D-transposition of the great arteries (n¼ 5), heterotaxy syn-
drome (n ¼ 3), severe coarctation or interrupted aortic arch
with ventricular septal defect (n ¼ 3), truncus arteriosus
(n ¼ 1), or total anomalous pulmonary venous return
(n ¼ 1). The 3 heterotaxy patients underwent a Ross proce-
dure, Blalock-Taussig shunt, and a hemi-Fontan operation.
On the basis of our composite definition, 17 (35%) patients
had a poor outcome. Three infants died, 2 required RRT, 12
had a prolonged time to first extubation, and 16 had a pro-
longed ICU length of stay. Both patients requiring RRT
were neonates whowere placed on ECMO support after sur-
gery owing to myocardial stun. In both cases, RRTwas ini-
tiated on postoperative day 2 owing to severe fluid overload.
Both of these patients died.
Patients with a poor outcome were more likely to be
younger and undergo more complex surgery with a longer
CPB time and use of hypothermic circulatory arrest
(Table 1). Postoperatively, patients with a poor outcome
had higher maximal vasoactive–inotropic score, were
more likely to require ECMO support, and had a higher
peak postoperative SCr. The majority of patients (86%)
met AKIN/KDIGO (Kidney Disease: Improving Global
Outcomes) stage I criteria (Scr rise of 50% or  0.3The Journal of Thoracic and Camg/dL); however, this AKI classification system did not dis-
tinguish between those infants with good and poor
outcomes.
Before patients underwent CPB, urinary concentrations
of NGAL, IL-18, cystatin C, and KIM-1 were low in all pa-
tients (Figure 1). With the exception of KIM-1, all bio-
markers demonstrated significant increases within 12
hours after bypass in patients with poor outcomes and
only minimal increases among patients with a good out-
come. The differences in urinary biomarker concentration
was significant at all postoperative time points for NGAL
and IL-18, but only within the first 2 hours postoperatively
for cystatin C. KIM-1 poorly differentiated patients with ei-
ther good or poor outcomes and was, therefore, removed
from further analysis.
Cutoffs to identify patients with poor outcomes were de-
termined using receiver operating characteristic curves for
NGAL, IL-18, and cystatin C (Table 2). All 3 biomarkers
performed well, with NGAL having the highest area under
the curve of 0.79. The time points most predictive of a poor
outcome occurred for NGAL at postoperative hour 12, IL-
18 at postoperative hour 6, and cystatin C at postoperative
hour 0 (Table 3). Of note, all 3 biomarkers showed better
negative than positive predictive values. Specifically, only
3 (9%) of 32 infants with a good outcome had an elevatedrdiovascular Surgery c Volume 146, Number 4 863
FIGURE 1. Biomarker profiles in infants undergoing cardiopulmonary bypass. Urinary concentrations of neutrophil gelatinase-associated lipocalin
(NGAL) (A), interleukin 18 (IL-18) (B), cystatin C (Cys C) (C), and kidney injury molecule-1 (KIM-1) (D) were determined by enzyme-linked immuno-
sorbent assay as described in the Methods section. Data are presented as median values in the good outcome (gray dotted line) versus poor outcome
(solid black line) groups. Error bars indicate interquartile range (25th-75th percentile). *P<.05.
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DNGAL at postoperative hours 6 and 12, 1 (3%) had an
elevated IL-18 at postoperative hour 6, and 4 (13%) had
elevated cystatin C at postoperative hour 2.
Having multiple elevated biomarkers on arrival to the
ICU (postoperative hour 0) was highly predictive of
a poor outcome (Table 3). Patients with both elevated
NGAL and IL-18 had a nearly 20-fold increased risk for
a poor outcome and patients with elevated NGAL, IL-18,
and cystatin C had a 24-fold increased risk. As with the sin-
gle biomarkers, the negative predictive value of havingmul-
tiple biomarkers below threshold was high.
Analysis of the NIRS data indicated that infants with
a poor outcome spent more cumulative time with rSO2 be-
low 50% than did those with good outcomes (Table 4,TABLE 2. Biomarker optimal cutoff values for prediction of a poor outco
Biomarker Optimal cutoff value (ng/mL) AUC Sensitivity
NGAL 76 0.79 0.64
IL-18 0.8 0.76 0.59
Cystatin C 179 0.69 0.51
AUC, Area under the receiver operating characteristic curve; NGAL, neutrophil gelatinase
864 The Journal of Thoracic and Cardiovascular SurgFigure E1). There were significant differences in cumula-
tive time below 50% starting at postoperative hour 2, and
after 24 hours of monitoring, poor outcome infants spent
nearly an hour more time below 50% than did those infants
who had a good outcome (1-2 minutes). Comparing patients
with single-ventricle versus biventricular physiology, we
found no difference in the time spent with NIRS rSO2 below
50% through the first 12 hours postoperatively, although
a difference did appear by the end of the NIRS monitoring
period (Table E1). Examining the ability of NIRS to corre-
late with markers of kidney injury, we examined the distri-
bution of low NIRS rSO2 and the presence of AKI, as
defined bymeeting AKIN stage 1 (Table E2), or urinary bio-
markers (Table E3). We found that there was no associationme
Specificity Positive predictive value Negative predictive value
0.87 0.72 0.83
0.86 0.68 0.80
0.79 0.55 0.76
-associated lipocalin; IL-18, interleukin 18.
ery c October 2013
TABLE 3. Risk of poor outcome for biomarker by threshold
Biomarker Postop hour
Poor outcome*
P value Odds ratio 95% CIYes (n ¼ 17) No (n ¼ 32)
NGAL  76 ng/mL 0 11 (65) 7 (22) .001 9.4 2.2, 39.0
2 10 (59) 4 (13) .002 9.4 2.0, 54.7
6 9 (53) 3 (9) .001 10.2 2.0, 72.9
12 11 (65) 3 (9) <.0001 18.7 3.4, 144
IL-18  0.8 ng/mL 0 9 (53) 4 (13) .004 9.1 1.8, 56.2
2 11 (65) 5 (16) .0004 11.0 2.6, 45.9
6 5 (29) 1 (3) .01 15.4 1.5, 813
12 4 (24) 3 (9) .24 2.7 0.4, 21.3
Cystatin C  179 ng/mL 0 9 (53) 8 (25) .01 5.2 1.3, 20.1
2 7 (41) 4 (13) .03 4.9 1.2, 20.4
6 8 (47) 6 (19) .05 3.7 0.9, 17.3
12 9 (53) 10 (31) .11 2.7 0.8, 9.3
NGAL  76 and IL-18  0.8 0 9 (53) 2 (6) .0002 19.7 3.1, 233
2 8 (47) 3 (9) .005 8.1 1.6, 58
6 3 (18) 1 (3) .11 6.4 0.5, 360
12 3 (18) 1 (3) .12 6.2 0.5, 348
NGAL 76, IL-18 0.8, and
Cystatin C  179
0 7 (41) 1 (3) .001 24.0 2.5, 1221
2 6 (35) 2 (6) .02 7.8 1.2, 90
6 2 (12) 1 (3) .27 4.0 0.2, 252
12 3 (18) 1 (3) .12 6.2 0.5, 348
CI, Confidence interval; NGAL, neutrophil gelatinase-associated lipocalin; IL-18, interleukin 18. *Data are presented as N (%).
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Dbetween NIRS rSO2 less than 50% and the presence of
AKI; however, in some cases, a NIRS rSO2 less than 50%
did correlate with elevated urinary biomarkers. Owing to
the small sample size, we were unable to evaluate outcomes
using a combination of cumulative time below 50% and
biomarker levels at the individual time points.
DISCUSSION
Biomarkers
Many recent studies have focused on the ability of renal
injury biomarkers to predict AKI before a rise in SCr
10,11,13
in a mixed-age pediatric population. We examined bio-
marker performance in relation to clinical outcomes in
a very young population and found, similar to the findings
in older patients, that within the first 12 hours of arrival to
the ICU after cardiac surgery, neonates and infants with el-
evated urinary NGAL, IL-18, and cystatin C were more
likely to have poor clinical outcomes. Importantly, to ourTABLE 4. Median cumulative time (in minutes) with NIRS saturation
below 50%
NIRS saturation
Postop
hours
Poor outcome
P valueYes (n ¼ 10) No (n ¼ 31)
<50% 2 1.0 (0.0-57.5) 0.0 (0.0-0.0) .02
6 3.5 (0.0-285.0) 0.0 (0.0-1.5) .03
12 17.2 (0.0-507.5) 0.0 (0.0-8.0) .08
24 59.5 (4.0-507.5) 1.5 (0.0-20.5) .02
Data are presented as median (interquartile range, 25th percentile-75th percentile) of
cumulative time spent with near-infrared spectroscopy (NIRS) saturation below 50%
from the beginning of monitoring until the indicated postoperative hour.
The Journal of Thoracic and Caknowledge, the negative predictive value of these bio-
markers has not been previously tested and emphasized in
infants. The majority of infants with good outcomes did
not have biomarker levels above the cohort-based calcu-
lated thresholds. In this study, an infant with a NGAL of
less than 76 ng/mL and an IL-18 of less than 0.8 ng/mL
in the first 2 hours after surgery had at least a 90% chance
of a good clinical outcome. Despite our broad definition of
poor outcome, the ability to predict a high likelihood of hav-
ing a good outcome within only 2 hours of surgery is not
only useful clinically but has implications for enrollment
in interventional trials, such that patients at low risk for
a poor outcome can be excluded, improving the risk/benefit
ratio for an experimental intervention. This concept has also
been proposed byWong and associates,23 who reported that
the negative predictive value of serum IL-8 could be used
for risk stratification before enrolment in pediatric septic
shock trials.
We found little diagnostic utility for KIM-1 in this study.
While Han and associates13 found that in a cohort of chil-
dren undergoing CPB, urinary KIM-1 detected AKI before
SCr, they did not correlate these findings with the same clin-
ical outcomes included in this study, other than the need for
RRT. Krawczeski and associates24 found that KIM-1 at 12
hours after CPB independently correlated with ventilator
time after adjusting for patient age, CPB time, and
RACHS-1 score. Whereas the median age of AKI patients
in that study was 6 months, the mean age of the present
study patients was 2 months, with a significant proportion
of neonates. Further study will be needed to determine therdiovascular Surgery c Volume 146, Number 4 865
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Dclinical utility of KIM-1 in neonates and infants less than 6
months of age.
We also evaluated the performance of NGAL, IL-18, and
cystatin C in combination and found the highest risk for
a poor outcome occurred in infants with elevations in all
3 biomarkers immediately after surgery. While Parikh and
coworkers12 found that urinary NGAL and IL-18 were
both strong predictors of severe AKI, defined as a 2-fold in-
crease in SCr or need for dialysis, the combination of these 2
biomarkers minimally improved predictive power. In con-
trast, Krawczeski and associates24 found that adding combi-
nations of the urinary biomarkers NGAL, IL-18, KIM-1,
and liver fatty acid–binding protein to a clinical model of
AKI risk factors improved the predictive ability of the
model in the first 24 hours after CPB. Although the concept
of a biomarker ‘‘panel’’ is appealing, more studies are
needed to determine the optimal timing and combination
that maximizes predictive power. Owing to differences in
organ maturity, it is possible that such a panel may be age
dependent (ie, the optimal panel and marker thresholds
for a child may be different from that which is most useful
in a neonate or infant).
Using AKIN/KDIGO stage 1 criteria, the incidence of
AKI in this study was 86%, which is higher than other con-
temporary infant cardiac surgical data.1,8,24 In addition, the
presence of AKI did not distinguish between those infants
with good or poor outcomes. This result is in contrast
with the findings of Blinder and coworkers,8 who found
that the presence of AKI correlated with mortality, duration
of mechanical ventilation, and prolonged ICU length of
stay. These differences may be due to the relatively small
sample size on our cohort, the use of a composite outcome
variable in this study, or the high proportion of neonates
who underwent complex RACHS-1 category 5 and 6
operations.
Near-Infrared Spectroscopy
Our study found that increased time spent with NIRS
rSO2 less than 50% was associated with a poor outcome.
Assuming that the NIRS probe is measuring the mixed ox-
ygen saturation of blood in the renal parenchyma, low rSO2
would be an indicator of poor renal oxygen delivery. Al-
though the exact threshold below which renal injury occurs
is not known, these results corroborate those of Owens and
colleagues,16 who showed that rSO2 less than 50% for more
than 2 hours correlated with higher serum creatinine values
and increased incidence of AKI in infants during the first 48
hours after CPB.
Our study included both single-ventricle and biventricu-
lar patients; however, there was no difference between these
2 groups in cumulative timewith rSO2 less than 50% during
the first 12 postoperative hours (see Table E1). This finding
is similar to the results published by Uebing and co-
workers,25 who found depressed cerebral oxygen866 The Journal of Thoracic and Cardiovascular Surgsaturations immediately after CPB in neonates who under-
went the Norwood and arterial switch operations and may
be attributable to a post-CPB effect on renal blood flow
rather than the presence or absence of a parallel circulation.
Our study was not large enough to analyze the predictive
power of the combination of renal NIRS and urinary bio-
markers to predict outcomes. We did, however, observe
that independent of outcome, higher urinary biomarker
levels correlated with lower duration of time with renal
NIRS rSO2 less than 50% (see Table E3). Although a sub-
stantial degree of renal injury occurs during CPB, it is pos-
sible that the real-time information obtained from NIRS
may compliment the data obtained from urinary bio-
markers, such that biomarkers would identify patients at
risk for AKI on arrival to the ICU. In doing so, NIRS would
provide a method for monitoring the effectiveness of post-
operative interventions by trending the rSO2. Further study
is needed to evaluate this hypothesis.CONCLUSIONS
Infants under 6 months of age with elevated urinary
NGAL, IL-18, and cystatin C immediately after CPB are
at increased risk for poor ICU outcomes. Increased duration
of renal NIRS rSO2 less than 50% in the first 24 hours after
CPB also predicts a poor clinical outcome. Importantly, in-
fants with low urinary biomarkers within the first 2 hours af-
ter bypass are likely to have a good ICU outcome, which can
help clinicians counsel families. These findings also under-
score the potential utility of urinary AKI biomarkers in
identifying infants at risk for poor outcomes, which can
aid in the development of prospective trials. Further studies
are needed to determine whether a panel of renal injury bio-
markers and renal NIRS can be used together and in the
postoperative management of infants after surgery for con-
genital heart disease.References
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TABLE E1. Comparison of cumulative time (in minutes) with NIRS
saturation below 50% between single- and biventricular circulations
NIRS
saturation Postop hours Single (n ¼ 7) Two (n ¼ 34) P value
<50% 2 0 (0, 60) 0 (0, 60) .20
6 0 (0, 286.5) 0 (0, 294) .50
12 9 (0, 646.5) 0 (0, 654) .12
24 89.5 (9.5,1327) 1.5 (0, 1356) .01
Data are presented as median (range, minimum-maximum). P value from Wilcoxon
rank sum test. NIRS, Near-infrared spectroscopy.
TABLE E2. Relationship of cumulative time (in minutes) with NIRS
saturation below 50% with AKI by AKIN categorization
NIRS
saturation Postop hours
AKI
P valueYes (n ¼ 34) No (n ¼ 7)
<50% 2 0 (0, 2) 0 (0, 0) .39
6 0 (0, 5.5) 0 (0, 0) .17
12 1.5 (0, 102) 0 (0, 4) .14
24 2.5 (0,127) 9.5 (0, 25) .96
Data are presented as median (interquartile range; 25th percentile, 75th percentile).
P value from Wilcoxon rank sum test. NIRS, Near-infrared spectroscopy; AKI, acute
kidney injury; AKIN, Acute Kidney Injury Network.
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FIGURE E1. Cumulative time with low renal near infrared spectroscopy
regional oxyhemoglobin saturation (rSO2). Median cumulative time spent
with rSO2 less than 50% in the good outcome (gray squares) versus poor
outcome (black circles) groups.
TABLE E3. Relationship of cumulative time (in minutes) with NIRS
saturation below 50% with each biomarker
NIRS
saturation Postop hours
NGAL
P value76 <76
<50% 2 0.75 (0, 3.75) 0 (0, 0) .02
6 2.25 (0, 168) 0 (0, 1.5) .045
12 4.75 (0, 507.5) 0.25 (0, 9) .30
24 137.75 (14, 416.75) 2 (0, 29.5) .07
NIRS
saturation Postop hours
IL-18
P value0.8 <0.8
<50% 2 0 (0, 2) 0 (0, 0) .35
6 226.5 (84, 285.75) 0 (0, 1.5) .02
12 304.75 (4, 527) 0 (0, 8) .03
24 583 3 (0, 59.5) .13
NIRS
saturation Postop hours
Cystatin C
P value179 <179
<50% 2 4.5 (0, 2) 0 (0, 0) .045
6 0 (0,3) 0 (0, 4.5) .96
12 5.25 (0, 304.75) 0 (0, 7) .08
24 109.5 (1.5, 399.5) 3 (0, 29.5) .42
Data are presented as median (interquartile range; 25th percentile, 75th percentile).
P value from Wilcoxon rank sum test. NIRS, Near-infrared spectroscopy;
NGAL, neutrophil gelatinase-associated lipocalin; IL-18, interleukin 18.
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